The Partnership for Part D Access is a collection of healthcare stakeholders, including patient groups, advocacy organizations and allied members of industry, who are committed to maintaining beneficiary access to the full range of available medications under Medicare Part D. We represent and care about individuals who would have been negatively impacted if the Centers for Medicare and Medicaid Services (CMS) were to move forward with a January 2014 proposal to end protected status for certain types of drugs under Medicare’s Six Protected Class policy, and to set the stage for removing others in the future. If this policy proposal—which CMS has decided to delay for consideration “in future years”—were to move forward, it would directly, and negatively, impact persons with mental illness, as well as those needing organ transplants. It could also affect people with epilepsy, Parkinson’s Disease, lupus, HIV/AIDS and cancer. Members of the Part D Partnership include:
Alkermes | Allergan | American Kidney Fund | American Osteopathic Association | American Society of Consultant Pharmacists | Anxiety and Depression Association of America | Cancer Support Community | Community Access National Network | Depression and Bipolar Support Alliance | Essential Health Benefits Coalition | Epilepsy Foundation | Lennox-Gastaut Syndrome Foundation | Leukemia and Lymphoma Society | Lundbeck | Mental Health America | Michael J. Fox Foundation | National Alliance on Mental Illness | National Council for Behavioral Health | National Alliance of State and Territorial AIDS Directors | National Kidney Foundation | Sunovion | Takeda | The AIDS Institute | The Janssen Pharmaceutical Companies of Johnson & Johnson | Transplant Recipients International Organization | Women Against Prostate Cancer
The Mission of the Partnership for Part D Access is to ensure that Medicare continues to provide beneficiaries with access to the vital and non-interchangeable medications under the policy known as Six Protected Classes.
Educate, engage and coordinate the efforts of affected patients and their allies to address this threat to Medicare beneficiary access to the most appropriate medications.
Educate federal policy makers on the history, rationale and importance of maintaining protected status for anticonvulsants, antidepressants, antineoplastics, antipsychotics, antiretrovirals, and immunosuppressants in Part D as part of the “Six Protected Classes.”
Implement effective advocacy and communications strategies to protect consumer access to the Six Protected Classes under Medicare Part D.
Executive Director, Partnership for Part D Access
Sr. Vice President, Public Policy and Practice Improvement
National Council for Behavioral Health
With more than 20 years of experience in behavioral health, Charles Ingoglia has worked as a provider, advocate, and educator for government and public sector organizations. Ingoglia directs the federal and state affairs function of the National Council for Behavioral Health, and oversees practice improvement and technical assistance programs offered to more than 500,000 behavioral health professionals across the U.S. His efforts have centered on key issues such as parity, healthcare reform, and improving the experience of mental heath and addictions care and treatment engagement.
Prior to joining the National Council, Ingoglia provided policy and program design guidance to the Substance Abuse and Mental Health Services Administration. He also has directed state government relations and service system improvement projects for the National Mental Health Association, served as a policy analyst for the National Association of Social Workers, and designed educational programs for mental health and addictions professionals at the Association of Ambulatory Behavioral Healthcare. He has worked in a transitional shelter with homeless persons and provided individual, group and couples counseling at the Whitman-Walker Clinic in Washington, DC. Ingoglia is adjunct faculty at the George Washington University Graduate School of Political Management.
Senior Advisor, Partnership for Part D Access
Partner, Thorn Run Partners
Catherine Finley has been helping to shape federal and state health care policy for over 15 years. Drawing on her extensive Capitol Hill and state experience, she brings a unique ability to identify public policy opportunities, develop effective lobbying strategies and achieve success by utilizing her wide network of bipartisan relationships with key decision-makers.
Ms. Finley previously served as Staff Director for the U.S. Senate Special Committee on Aging, where she oversaw committee operations on behalf of Senator Gordon H. Smith (R-OR), during his tenure as both chair and ranking member. As Staff Director, Ms. Finley was the Senator's lead negotiator on critical health care legislation involving Medicare, Medicaid and the Children's Health Insurance Program. She also led Senator Smith's health and human services legislative agenda related to the Senate Finance Committee; the Senate Health, Education, Labor and Pensions (HELP) Committee; and the Senate Appropriations Subcommittee on Labor-HHS-Education. Ms. Finley has also served as Senior Health Policy advisor for Senator Olympia J. Snowe (R-ME), where she advised the Senator on all health and human services issues, including development and enactment of the Medicare Modernization Act.